
Caberlee 0.25mg Tablet
Marketer
Johnlee Pharmaceuticals Pvt Ltd
Salt Composition
Cabergoline (0.25mg)
Overview Caberlee 0.25mg Tablet
Bromocriptine 0.25mg tablets function as a dopamine agonist, primarily treating elevated prolactin levels. This medication also aids in suppressing lactation following stillbirth, abortion, or miscarriage. For optimal absorption, consume Caberlee 0.25mg with food, maintaining consistent daily timing. Dosage and frequency are determined by your physician based on your specific condition and response. Always follow your doctor's instructions. Swallow tablets whole with water. Continue treatment as directed by your doctor. Common side effects include nausea, headache, lightheadedness, and hypotension. Report any concerning side effects to your physician; management strategies may be available. To mitigate dizziness, avoid driving and rise gradually from a seated or supine position. Inform your physician of any history of postpartum hypertension, cardiac disease, pregnancy (current or planned), breastfeeding, or other medications you are currently using, as interactions may impact efficacy or alter the drug's effects. Regular blood pressure monitoring may be conducted during treatment.
Primary Ingredients of Caberlee 0.25mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Caberlee 0.25mg Tablet
Managing hyperprolactinemia
Major Benefits of Caberlee 0.25mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Caberlee 0.25mg Tablet should be administered with a meal.
Common Side effects of Caberlee 0.25mg Tablet:
- Nausea
- Constipation
- Dizziness
- Fatigue
- Headache
- Vomiting
- Vertigo
- Abdominal pain
- Breast pain
- Sleepiness
- Valvulopathy and related disorders
- Dyspepsia
- Gastritis
- Weakness
- Depression
- Postural hypotension (low blood pressure)
- Hot flushes
How to use Caberlee 0.25mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Caberlee 0.25mg Tablet should be administered with a meal.
How Caberlee 0.25mg Tablet works:
Caberlee 0.25mg tablets reduce prolactin levels, a hormone responsible for lactation. This action suppresses breast milk production following stillbirth, abortion, or miscarriage.
SAFETY ADVICE
AlcoholCAUTION
Use of Caberlee 0.25mg Tablet with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Caberlee 0.25mg tablets is contraindicated during pregnancy due to established risks to the fetus. In exceptional life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Caberlee 0.25mg Tablet while breastfeeding is likely unsafe. Available data in humans indicate potential transfer to breast milk, posing a risk to the infant. Caberlee 0.25mg Tablet is typically avoided during lactation due to its lactation-suppressing effect.
DrivingUNSAFE
Taking a 0.25mg Caberlee tablet might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
The use of 0.25mg Caberlee tablets in individuals with kidney disease is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Caberlee 0.25mg tablets cautiously. Dosage modification for Caberlee 0.25mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Caberlee 0.25mg Tablet :
Omit a missed dose of Caberlee 0.25mg Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Caberlee 0.25mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Ergoline alkaloids |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
| Actions | Elevated Prolactin Levels and Dopamine Agonists |
